Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Scandinavian Journal of Urology and Nephrology|September 1, 2007
Pyelovenous backflow or veno-caliceal valve fistula?Hossein Tezval, Ira Matuschek, Udo Jonas
Analytical and Bioanalytical Chemistry|December 12, 2003
Characterization of peptide-protein interactions using photoaffinity labeling and LC/MSOlaf Jahn, Klaus Eckart, Hossein Tezval, et al.
International Urology and Nephrology|August 13, 2014
Connection between expression of inducible nitric oxide synthase (iNOS) in skull base chordoma and lower urinary tract symptomsReza Akhavan-Sigari, Helmut Ostertag, Veit Rohde, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 7, 2002
The binding protein of corticotropin-releasing factor: ligand-binding site and subunit structureOlaf Jahn, Klaus Eckart, Olaf Brauns, et al.
Neuroscience and Biobehavioral Reviews|August 16, 2005
The role of CRF receptors in anxiety and depression: implications of the novel CRF1 agonist cortagineCedomir Todorovic, Olaf Jahn, Hossein Tezval, et al.
Neuropharmacology|June 30, 2004
Three-amino acid motifs of urocortin II and III determine their CRF receptor subtype selectivityOlaf Jahn, Hossein Tezval, Lars van Werven, et al.
Mini Reviews in Medicinal Chemistry|October 28, 2005
Corticotropin-releasing factor binding protein--a ligand trap?Olaf Jahn, Jelena Radulovic, Oliver Stiedl, et al.
Clinics and Practice|December 24, 2025
Urinary Bladder Hamartoma: Narrative Literature Review of an Exotic Pathology and Rare Cause of LUTSMohammed Rafea Kanaan, Meryem Akkoyun, Marcel Lafos, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 12, 2004
Cortagine, a specific agonist of corticotropin-releasing factor receptor subtype 1, is anxiogenic and antidepressive in the mouse modelHossein Tezval, Olaf Jahn, Cedomir Todorovic, et al.
BMC Cancer|October 6, 2025
Comparison of molecular profiles (Nectin-4 and TROP-2) in upper tract urothelial carcinoma with a positive history of urinary bladder cancer vs. UTUC only in the era of ADCsMohammed Rafea Kanaan, Jessica Schmitz, Jan Hinrich Braesen, et al.
Pageof 5